• Home
  • /
  • Pharmacovigilance in Ensuring Drug Safety and Patient Welfare
Find a workshopPay feeRequest a callbackVerify a certificate
Biotechnology · Moderate · Video-based learning

Pharmacovigilance in Ensuring Drug Safety and Patient Welfare

Pharmacovigilance: Protecting Patients, Ensuring Safe Medicines

Access 24/7 · 365 daysVideo lectures of 3+ hrsCertificate
Registration open

About This Course

Pharmacovigilance in Ensuring Drug Safety and Patient Welfare is a critical resource for healthcare and pharmaceutical professionals, focusing on effective pharmacovigilance practices to detect, assess, and prevent adverse drug effects, thereby enhancing patient safety and ensuring compliance with global regulatory standards.

Aim

The aim of this guide is to empower healthcare and pharmaceutical professionals with advanced pharmacovigilance skills, enhancing their ability to monitor, analyze, and report adverse drug reactions. This knowledge ensures higher drug safety standards, better patient outcomes, and compliance with regulatory requirements, fostering a safer healthcare environment

Course Objectives

  • Understand Pharmacovigilance Principles: Gain a deep understanding of the fundamental principles of pharmacovigilance, including its scope and significance in healthcare.
  • Enhance Drug Safety Monitoring: Learn techniques for effectively monitoring and reporting adverse drug reactions to improve drug safety.
  • Promote Patient Safety: Emphasize the implementation of strategies that ensure patient safety and minimize risks associated with medication use.
  • Support Regulatory Compliance: Provide knowledge on current regulatory requirements and how to comply with them to ensure the efficacy and safety of drugs.
Next: Syllabus →

Syllabus

Module 1 :

Session 1: Introduction to Pharmacovigilance
● Overview and Importance of Pharmacovigilance
○ Definition and objectives
○ Importance in ensuring drug safety and patient welfare

Session 2: Adverse Drug Reactions (ADRs)
● Definition, Classification, Identification, Assessment, and Reporting of ADRs
○ Types of ADRs
○ Methods for identification and assessment
○ Reporting mechanisms and regulatory requirements

Session 3: Tools and Techniques for ADR Detection and Signal Management
● Tools and methodologies for ADR detection
● Signal management principles and techniques
● Case Studies: Analyzing and managing safety signals

Module 2:

Session 4: Pharmacovigilance in Clinical Trials
● Role of Pharmacovigilance in Clinical Trial Safety Monitoring
○ Adverse event reporting in clinical trials
○ Risk management strategies and minimization measures
● Pharmacovigilance Planning and Risk Management Plans
Session 5: Signal Detection and Risk Management
● Principles of Signal Detection and Signal Management
○ Tools and methodologies for signal detection and assessment
○ Case Studies: Analyzing and managing safety signals

Session 6: Pharmacovigilance Audits, Inspections, and Special Populations

  • Overview of Pharmacovigilance Audits and Inspections
    ● Pharmacovigilance Considerations in Special Populations

Module 3:

Session 7: Recent Advancements in Pharmacovigilance

  • Overview of Recent Advancements
    ○ Real-world evidence and big data analytics
    ○ Artificial intelligence and machine learning applications
    ○ Integration of electronic health records (EHRs) and patient-reported outcomes
    ○ Global pharmacovigilance harmonization efforts

Session 8: Communication and Reporting

  • Effective Communication of Drug Safety Information
    ○ To healthcare professionals and the public
    ● Practical Exercises: Preparing Pharmacovigilance Reports and Communication
    Materials
    Session 9: Future of Pharmacovigilance
  • Digital Pharmacovigilance and the Role of Artificial Intelligence
    ● Discussion on Future Challenges and Opportunities in Pharmacovigilance

Who Should Enrol?

  • Students: Undergraduate and graduate students in pharmacy, medicine, and health sciences interested in drug safety and pharmacovigilance.
  • PhD Scholars: Researchers studying drug interactions, adverse effects, or any pharmacological aspects that directly impact patient care.
  • Academicians: Faculty members teaching pharmacology, clinical medicine, or pharmacy who integrate pharmacovigilance into their curriculum.
  • Industry Professionals: Healthcare professionals, regulatory affairs specialists, and pharmaceutical industry personnel involved in drug safety monitoring.

Course Outcomes

  • Adverse Drug Reaction Identification: Ability to identify and understand the mechanisms of adverse drug reactions.
  • Data Analysis Skills: Proficiency in analyzing pharmacovigilance data to discern patterns that indicate potential safety issues.
  • Reporting and Communication: Skills in accurately documenting and reporting adverse effects as per regulatory standards.
  • Risk Management: Capability to develop and implement risk management strategies in clinical and pharmaceutical settings.
Next: Fees →

Course fee

Learners in India

₹2,499

Learners outside India

$50

  • Video lectures
  • Study material
  • Certificate after completion
  • 365-day access

Enrol in the course

Next: FAQ →

Frequently asked questions

How is this course taught?

Through recorded video lectures from the original live workshop, with the study material. Watch at your own pace, any time.

How long do I have access?

365 days from your registration, on your NanoSchool dashboard.

Do I get a certificate?

Yes, an e-certificate after completion, with a QR code anyone can verify and an "Add to LinkedIn" button.

How can I pay?

By card, UPI or PayPal on the payment page; international bank transfer is also available there.

What is the refund policy?

See our Returns, Refunds & Cancellation policy: Returns, Refunds & Cancellation policy

Need Help?

We’re here for you!


(+91) 120-4781-217
WhatsApp +91 99581 61117

Registration open

More upcoming workshops

Live, mentor-led and certified. Dates and times in IST.

See all workshops
Support